Cargando…

Case report: Successful treatment of non-bullous lichen planus pemphigoides with dupilumab

Lichen planus pemphigoides (LPP) is a rare autoimmune bullous disease, characterized by the coexistence of lichen planus and subepidermal bullae. However, the minority of LPP patients present with papules rather than vesicles or blisters, which is defined as non-bullous LPP. The diagnosis of LPP rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Si-Zhe, Xie, Ying-Han, Wang, Si-Hang, Fang, Rou-Yu, Jin, Hong-Zhong, Zuo, Ya-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800862/ https://www.ncbi.nlm.nih.gov/pubmed/36590953 http://dx.doi.org/10.3389/fmed.2022.1023458

Ejemplares similares

Lichen planus pemphigoides successfully treated with dupilumab
por: Ch’en, Peter Yi, et al.
Publicado: (2022)

Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
por: Wang, Si-Hang, et al.
Publicado: (2021)

Bullous Lichen Planus vs Lichen Planus Pemphigoides: A Diagnostic Dilemma
por: Tripathy, Durga M., et al.
Publicado: (2022)

Non-bullous Lichen Planus Pemphigoides: A Case Report
por: LAMBERTS, Aniek, et al.
Publicado: (2020)

The Successful Treatment of COVID-19-Induced Bullous Pemphigoid With Dupilumab
por: Savoldy, Michelle A, et al.
Publicado: (2022)

Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types
por: Yan, Tianmeng, et al.
Publicado: (2023)

Vulvar lichen planus pemphigoides()()
por: Loyal, J., et al.
Publicado: (2017)

Lichen planus pemphigoides: A unique form of bullous and lichenoid eruptions secondary to nivolumab
por: Shah, Rohan R., et al.
Publicado: (2022)

Paradoxical phenomena of bullous pemphigoid induced and treated by identical biologics
por: Zhang, Jie, et al.
Publicado: (2023)

Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
por: Zhang, Yihua, et al.
Publicado: (2021)

Successful Treatment of Psoriasis Combined with Bullous Pemphigoid with Dupilumab: A Case Report
por: Liu, Jing-Hua, et al.
Publicado: (2023)

Differential diagnosis between pemphigoid and erosive lichen planus
por: Cheng, Zhe, et al.
Publicado: (2022)

Use of Dupilumab in Bullous Pemphigoid: Where Are We Now?
por: Russo, Roberto, et al.
Publicado: (2022)

Recalcitrant bullous pemphigoid responsive to dupilumab in an adolescent patient
por: Zhou, Albert E., et al.
Publicado: (2022)

Effect of Dupilumab on Generalized Verrucosis in Refractory Bullous Pemphigoid
por: WANG, Qijun, et al.
Publicado: (2023)

Thymic Stromal Lymphopoietin Is Implicated in the Pathogenesis of Bullous Pemphigoid by Dendritic Cells
por: Li, Si-Zhe, et al.
Publicado: (2020)

Skin-infiltrating T cells display distinct inflammatory signatures in lichen planus, bullous pemphigoid and pemphigus vulgaris
por: Schinner, Jona, et al.
Publicado: (2023)

Narrowband UVB-induced lichen planus pemphigoide
por: Mandy Chan, Wai Man, et al.
Publicado: (2011)

Childhood lichen planus pemphigoides triggered by chickenpox
por: Mohanarao, T. S., et al.
Publicado: (2014)

Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid
por: Seyed Jafari, S. Morteza, et al.
Publicado: (2021)

Successful Treatment of Resistant Lichen Planus Pemphigoides with Cyclosporine: A New Hope
por: Malakar, Subrata, et al.
Publicado: (2016)

Bullous oral lichen planus: An unusual variant
por: Jindal, Rashmi, et al.
Publicado: (2011)

Bullous Lichen Planus: Case Report and Review
por: Babu, Abhilesh, et al.
Publicado: (2019)

Lichen Planus
por: Boch, Katharina, et al.
Publicado: (2021)

Dupilumab for the treatment of pembrolizumab‐induced bullous pemphigoid: A case report
por: Pop, Samantha R., et al.
Publicado: (2022)

Effectiveness and safety of Dupilumab for the treatment at 104 weeks of recalcitrant bullous pemphigoid
por: Manzo Margiotta, Flavia, et al.
Publicado: (2023)

Anti-interleukin 4 receptor α antibody for the treatment of Chinese bullous pemphigoid patients with diverse comorbidities and a 1-year follow-up: a monocentric real-world study
por: Wang, Si-Hang, et al.
Publicado: (2023)

Differential diagnosis between pemphigoid and erosive lichen planus
por: Saglam, Ebru, et al.
Publicado: (2022)

Coexistence of Anti-p200 Pemphigoid and Psoriasis: A Systematic Review
por: Xie, Ying-Han, et al.
Publicado: (2022)

Case Report: The First Reported Case of Bullous Lichen Planus-Systemic Lupus Erythematosus Overlap Syndrome
por: Liu, Yi, et al.
Publicado: (2021)

Bullous Pemphigoid Complicated by Sepsis
por: Shah, Dipal, et al.
Publicado: (2022)

Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review
por: Cao, Peng, et al.
Publicado: (2022)

Treatment of lichen planus pemphigoides with mesalamine: novel use of this drug()
por: Gandhi, Vijay, et al.
Publicado: (2022)

A Case of Lichen Planus Pemphigoides Successfully Treated with a Combination of Cyclosporine A and Prednisolone
por: Washio, Ken, et al.
Publicado: (2013)

Successful treatment of Brunsting-Perry pemphigoid with dupilumab
por: Blum, Franklin R., et al.
Publicado: (2021)

Severe pemphigoid nodularis successfully treated with dupilumab
por: Jendoubi, Fatma, et al.
Publicado: (2022)

Oral bullous lichen planus: Case report and review of management
por: Patil, Archana, et al.
Publicado: (2012)

Dupilumab-Induced Lichen Planus: A Case with Oral and Cutaneous Eruptions
por: Kern, Laura, et al.
Publicado: (2022)

Lichen planus pigmentosus
por: Bourra, Hayat, et al.
Publicado: (2013)

Lichen planus pigmentosus
por: Bourra, Hayat, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vsd5huh0f48tlohspih6vsptgt